Use of selective ligands for treatment of disease states responsive to steroid or steroid-like retinoids
US5668175A · kind A · utility
57Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 12, 1996 |
| Grant date | Sep 16, 1997 |
| Priority date | — |
| Expiry date | Aug 12, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/196
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
In accordance with the present invention, there is provided a method for the treatment of subjects afflicted with steroid or steroid-like hormone-responsive disease states. The invention method comprises administering to the subject an effective amount of a ligand which selectively interacts with the receptor subtype associated with the steroid or steroid-like hormone-responsive disease state, wherein said ligand interacts with said receptor subtype to a significantly greater extent than with other subtypes of the same receptor class.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.